BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 11047757)

  • 21. The carboxyl-terminal region of IkappaB kinase gamma (IKKgamma) is required for full IKK activation.
    Makris C; Roberts JL; Karin M
    Mol Cell Biol; 2002 Sep; 22(18):6573-81. PubMed ID: 12192055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations.
    Orange JS; Brodeur SR; Jain A; Bonilla FA; Schneider LC; Kretschmer R; Nurko S; Rasmussen WL; Köhler JR; Gellis SE; Ferguson BM; Strominger JL; Zonana J; Ramesh N; Ballas ZK; Geha RS
    J Clin Invest; 2002 Jun; 109(11):1501-9. PubMed ID: 12045264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival.
    Nishikomori R; Akutagawa H; Maruyama K; Nakata-Hizume M; Ohmori K; Mizuno K; Yachie A; Yasumi T; Kusunoki T; Heike T; Nakahata T
    Blood; 2004 Jun; 103(12):4565-72. PubMed ID: 14726382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An atypical case of incontinentia pigmenti with a hypomorphic variant.
    Guo Y; Bu W; Jia W; Zhang Y; Li C
    Pediatr Dermatol; 2024; 41(2):351-353. PubMed ID: 37853991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations.
    Fusco F; Pescatore A; Bal E; Ghoul A; Paciolla M; Lioi MB; D'Urso M; Rabia SH; Bodemer C; Bonnefont JP; Munnich A; Miano MG; Smahi A; Ursini MV
    Hum Mutat; 2008 May; 29(5):595-604. PubMed ID: 18350553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti.
    Makris C; Godfrey VL; Krähn-Senftleben G; Takahashi T; Roberts JL; Schwarz T; Feng L; Johnson RS; Karin M
    Mol Cell; 2000 Jun; 5(6):969-79. PubMed ID: 10911991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypohidrotic ectodermal dysplasia: argument against an autosomal recessive form clinically indistinguishable from X-linked hypohidrotic ectodermal dysplasia (Christ-Siemens-Touraine syndrome).
    Sybert VP
    Pediatr Dermatol; 1989 Jun; 6(2):76-81. PubMed ID: 2748478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A point mutation in NEMO associated with anhidrotic ectodermal dysplasia with immunodeficiency pathology results in destabilization of the oligomer and reduces lipopolysaccharide- and tumor necrosis factor-mediated NF-kappa B activation.
    Vinolo E; Sebban H; Chaffotte A; Israël A; Courtois G; Véron M; Agou F
    J Biol Chem; 2006 Mar; 281(10):6334-48. PubMed ID: 16379012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The range of defects associated with nuclear factor kappaB essential modulator.
    Uzel G
    Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):513-8. PubMed ID: 16264331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation.
    Fusco F; Bardaro T; Fimiani G; Mercadante V; Miano MG; Falco G; Israël A; Courtois G; D'Urso M; Ursini MV
    Hum Mol Genet; 2004 Aug; 13(16):1763-73. PubMed ID: 15229184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti.
    Bal E; Laplantine E; Hamel Y; Dubosclard V; Boisson B; Pescatore A; Picard C; Hadj-Rabia S; Royer G; Steffann J; Bonnefont JP; Ursini VM; Vabres P; Munnich A; Casanova JL; Bodemer C; Weil R; Agou F; Smahi A
    J Allergy Clin Immunol; 2017 Dec; 140(6):1671-1682.e2. PubMed ID: 28249776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
    Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
    Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NEMO gene mutations in Chinese patients with incontinentia pigmenti.
    Hsiao PF; Lin SP; Chiang SS; Wu YH; Chen HC; Lin YC
    J Formos Med Assoc; 2010 Mar; 109(3):192-200. PubMed ID: 20434027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations.
    Aradhya S; Woffendin H; Jakins T; Bardaro T; Esposito T; Smahi A; Shaw C; Levy M; Munnich A; D'Urso M; Lewis RA; Kenwrick S; Nelson DL
    Hum Mol Genet; 2001 Sep; 10(19):2171-9. PubMed ID: 11590134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two novel mutations in the gene EDAR causing autosomal recessive hypohidrotic ectodermal dysplasia.
    Naqvi SK; Wasif N; Javaid H; Ahmad W
    Orthod Craniofac Res; 2011 Aug; 14(3):156-9. PubMed ID: 21771270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Two neonates with vesicular skin lesions due to incontinentia pigmenti].
    Winterberg DH; van Tijn DA; Smitt JH; Winterberg S; Vomberg PP
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2178-82. PubMed ID: 11727618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
    Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
    Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherited disorders of NF-kappaB-mediated immunity in man.
    Puel A; Picard C; Ku CL; Smahi A; Casanova JL
    Curr Opin Immunol; 2004 Feb; 16(1):34-41. PubMed ID: 14734108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [NEMO Delta 4-10 deletion of NEMO gene in Chinese incontinentia pigmenti cases].
    Li L; Song GW; DU JB; Liu JR; Xu FS; Liu XY; Zhang T
    Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):89-92. PubMed ID: 15833158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherited disorders of human Toll-like receptor signaling: immunological implications.
    Ku CL; Yang K; Bustamante J; Puel A; von Bernuth H; Santos OF; Lawrence T; Chang HH; Al-Mousa H; Picard C; Casanova JL
    Immunol Rev; 2005 Feb; 203():10-20. PubMed ID: 15661018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.